Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael J Gaziano, MD MPH
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Study Chair - Nicholas L. Smith, PhD
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, Ma
Boston, Massachusetts, United States
- Va Puget Sound Health Care System Seattle Division, Seattle, Wa
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2020
- Primary completion
- 1 Oct 2021
- Completion
- 1 Oct 2021
- Last update posted
- 4 Apr 2024
- Registered enrollment
- 5,044
- Registry id
- NCT04545047
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.